Richard Edwin PratleyBS, MD
Dr. Pratley has served as Head of the Diabetes and Metabolism Unit of the National Institutes of Health Clinical Diabetes and Nutrition Section in Phoenix, Arizona, leading the push for nationally funded studies in diabetes and metabolic diseases. He then took a position as Senior Director in the Cardiovascular and Metabolism Therapeutic Area at Novartis Pharmaceuticals where he worked on the clinical development of new drugs for diabetes. Afterward, from 2004 to 2011, Dr. Pratley was the Director of University of Vermont’s Diabetes and Metabolism Translational Medicine Unit and a professor at their College of Medicine. There he led many large-scale investigations, including NIH and pharmaceutical company sponsored studies.
Dr. Pratley is a graduate of Wayne State University School of Medicine in Detroit, Michigan, and trained in internal medicine from the University of Michigan in Ann Arbor. He gained further experience in geriatrics and gerontology at the University of Michigan, Johns Hopkins University, and the National Institutes of Health (NIH) National Institute on Aging in Baltimore, Maryland. His current research interests include the prevention of diabetes, improving the care for persons with diabetes, developing new drugs to treat and prevent diabetes and its complications and understanding the role of the fat cell in increasing the risk for diabetes and heart disease.